ACAD compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

ACADAcadia Pharmaceuticals Inc

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

ACADAcadia Pharmaceuticals Inc

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ACAD

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±15.9%▼−1.07%×0.07

Q2 FY26±11.9%▲+6.08%×0.51

May 7 '26±13.4%▲+5.03%×0.37

Q1 FY26±9.4%▼−1.32%×0.14

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedACAD realized, solidLLY realized, hatchedOne scale, both sides: full bar = 16%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

ACADAcadia Pharmaceuticals Inc

21.23▼−0.03%· post 21.23

Mkt cap$3.7BRevenue$342MQ3 FY26Revenue$1.1BFY25

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,358.90

ClosedNov 6 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 6 '26

ACADAcadia Pharmaceuticals Inc

LLYELI Lilly & Co

21.23▼−0.03%post 21.23

Price

1,360.90▼−0.28%post 1,358.90

$3.7B

Mkt cap

$1.2T

Q3 FY26$342M

Revenue

$24.4BQ3 FY26

FY25$1.1B

Revenue

$65.2BFY25

ACAD21.23▼−0.03%vsLLY1,360.90▼−0.28%ClosedNov 6 '26